Table 5.

Adverse events (occurring after baseline but before recurrence of parasitaemia in > 2% of children) suspected by investigators to be related to study medication by body weight group

Adverse Events	n (%)
	BWG1 5-<10 kg (N = 50)	BWG2 10-<15 kg (N = 37)	BWG3 15-<25 kg (N = 16)	Total 5-<25 kg (N = 103)
At least one adverse event	30 (60.0)	16 (43.2)	6 (37.5)	52 (50.5)
Anaemia	7 (14.0)	6 (16.2)	1 (6.3)	14 (13.6)
Diarrhoea	5 (10.0)	5 (13.5)	1 (6.3)	11 (10.7)
Clonus	7 (14.0)	5 (13.5)	1 (6.3)	13 (12.6)
Vomiting	7 (14.0)	0 (-)	4 (25.0)	11 (10.7)
Rashes	4 (8.0)	3 (8.1)	0 (-)	7 (6.8)
Hyperreflexia	1 (2.0)	2 (5.4)	1 (6.3)	4 (3.9)
Cough	2 (4.0)	1 (2.7)	0 (-)	3 (2.9)